tiprankstipranks
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market
ABCL
AbCellera Biologics
RESEARCH TOOLSreports
Want to see ABCL full AI Analyst Report?

AbCellera Biologics (ABCL) Income Statement

2,329 Followers

AbCellera Biologics Income Statement

Last quarter (Q4 2025), AbCellera Biologics's total revenue was $44.85M, an increase of 788.20% from the same quarter last year. In Q4, AbCellera Biologics's net income was $-8.95M. See AbCellera Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 75.13M$ 28.83M$ 38.02M$ 485.42M$ 375.20M
Gross Profit
$ 75.13M$ 28.83M$ 38.02M$ 418.99M$ 329.69M
Operating Expenses
$ 292.23M$ 343.60M$ 275.23M$ 202.48M$ 125.27M
Depreciation and Amortization
$ 22.17M$ 97.00M$ 30.89M$ 33.10M$ 17.25M
EBITDA
$ -155.42M$ -204.15M$ -192.16M$ 260.17M$ 239.15M
Operating Income
$ -217.10M$ -314.77M$ -237.21M$ 216.51M$ 204.41M
Other Income/Expenses
$ 39.51M$ 114.37M$ 63.18M$ 22.59M$ 14.74M
Pretax Income
$ -177.59M$ -200.40M$ -174.03M$ 239.10M$ 219.15M
Net Income
$ -146.41M$ -162.86M$ -146.40M$ 158.52M$ 153.46M
Per Share Metrics
Basic EPS
$ -0.49$ -0.55$ -0.51$ 0.56$ 0.56
Diluted EPS
$ -0.49$ -0.55$ -0.51$ 0.50$ 0.48
Weighted Average Shares Outstanding
 298.71M 294.33M 289.17M 285.06M 275.76M
Weighted Average Shares Outstanding (Diluted)
 298.71M 294.33M 289.17M 314.83M 318.29M
Currency in USD

AbCellera Biologics Earnings and Revenue History